StockData
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU

Drugs Made In America Acquisition II Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.18−0.00 (-0.05%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Drugs Made In America Acquisition II Corp. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Drugs Made In America Acquisition II does not break out revenue by segment, region or product in the tagged data of its filings for this period type.